The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

molecularproducts.com

Founded Year

1924

Stage

Acq - Fin | Alive

Total Raised

$6.55M

About Molecular Products Group

Molecular Products is a manufacturer of advanced chemistry-based products serving the healthcare, defense, and industrial markets. The Company primarily specializes in the manufacture and supply of chemical technologies for the treatment of breathable gases and is able to serve its customer base out of its two primary manufacturing facilities in Harlow, Essex, U.K. and Boulder, CO.

Molecular Products Group Headquarter Location

Parkway, Harlow Business Park Harlow

Essex, England, CM19 5FR,

United Kingdom

+44 (0)1279 445111

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Molecular Products Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Molecular Products Group is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,909 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

Molecular Products Group Patents

Molecular Products Group has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/11/2014

11/6/2018

Industrial gases, Gas technologies, Oxidizing agents, Chemical processes, Diving medicine

Grant

Application Date

12/11/2014

Grant Date

11/6/2018

Title

Related Topics

Industrial gases, Gas technologies, Oxidizing agents, Chemical processes, Diving medicine

Status

Grant

Latest Molecular Products Group News

The O.C. Molecular Products Group, an Arlington Capital Partners Portfolio Company, Announces Acquisition of the O.C

Nov 4, 2019

Lugo Company. Lugo Company, located in Connellsville, PA, manufactures sodium chlorate-based chemical oxygen generators, and is a prime contractor for the United States Navy. Chemical oxygen generators are devices used to produce pure, breathable oxygen for use in enclosed spaces, including submarines. Troy Rhudy, CEO of the Molecular Products Group, said, “As the world leader in chemical oxygen generation systems, Molecular Products is excited to welcome the O.C. Lugo Company into the Group. Our combined capabilities will support our continued growth in the defense industry while strengthening our service to our global customer base.” “The acquisition of the O.C. Lugo Company demonstrates Molecular Products’ continued investment in its market-leading chemical oxygen generation franchise. The transaction expands the Company’s product offerings and provides another key chemical oxygen generator manufacturing site in addition to our existing capacity in Harlow, England and in our state-of-the-art Louisville, CO facility,” said Peter Manos, a Managing Partner at Arlington Capital Partners. Malcolm Little, a Partner at Arlington Capital, added, “This is Molecular Products’ second strategic acquisition in the last twelve months. We are very excited for the tremendous growth opportunities these highly complementary acquisitions bring in each of Molecular Products’ core markets.” About Molecular Products Molecular Products is a Pure Air Technologies company and leading manufacturer of advanced chemistry-based products serving the healthcare, defense and industrial markets. The Company specializes in the manufacture and supply of chemical technologies for the treatment of breathable gases and serves its global customer base out of its two primary manufacturing facilities in Louisville, Colorado, USA and Harlow, Essex, UK. About Arlington Capital Partners Arlington Capital Partners is a Washington, D.C.-area private equity firm that has managed $4.0 billion of committed capital via five investment funds. Arlington Capital is focused on middle market investment opportunities in growth industries, including: aerospace/defense, government services and technology, healthcare, and business services and software. The firm’s professionals and network have a unique combination of operating and private equity experience that enable Arlington Capital to be a value-added investor. Arlington Capital invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their company’s position as leading competitors in their field. www.arlingtoncap.com Contacts

Molecular Products Group Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Molecular Products Group Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.